Material matter affecting investment judgment (clinical trial plan amendment applied for)
DART
GI Innovation, Inc.
Filed Jun 8, 2026 KST · Filing
· receipt 20260608900888
kstock has not written this one up.
The title above is a translation of the Korean form name; the filing itself is on DART, in
Korean.
Read the original on DART ↗Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory
Service — the filing equivalent of EDGAR.
Korean form name: 투자판단관련주요경영사항(임상시험계획변경승인신청) (진행성 또는 전이성 고형암 시험대상자를 대상으로 GI108 단일 요법의 안전성, 내약성, 약동학 및 치료효과를 평가하기 위한 제1/2a상 임상시험 계획 변경승인신청)